Table 2.
Gene name | Type I | Type II | Type III |
---|---|---|---|
ACCS | X | ||
APCS | X | ||
APOBEC3A | X | X | |
APOBEC3G | X | X | |
APOL1 | X | X | |
APOL3 | X | X | |
CD5L | X | ||
CFB | X | X | |
CMPK2 | X | X | |
CNTRL | X | ||
CX3CL1 | X | X | |
CXCL10 | X | X | |
CXCL11 | X | X | |
DCK | X | X | |
DDX58 | X | X | X |
DDX60 | X | X | |
DDX60L | X | X | |
DHX58 | X | X | |
DNAAF1 | X | ||
EIF2AK2 | X | X | X |
EPSTI1 | X | X | X |
FGL2 | X | X | |
GBP1 | X | X | X |
GBP4 | X | X | |
GBP5 | X | X | |
GCH1 | X | X | |
GZMB | X | X | |
H1FX | X | ||
HELZ2 | X | X | X |
HERC5 | X | X | |
HERC6 | X | X | X |
HMGB2 | X | ||
HP | X | X | |
ICAM1 | X | X | |
IDO1 | X | X | |
IFI44 | X | X | |
IFIH1 | X | X | X |
IFIT1 | X | X | X |
IFIT2 | X | X | X |
IFIT3 | X | X | X |
IFIT5 | X | X | X |
IL4I1 | X | X | |
INO80 | X | ||
IRF9 | X | X | X |
ISG15 | X | X | X |
ISG20 | X | X | |
KCNAB2 | X | ||
KRT13 | X | ||
LCP2 | X | X | |
LILRA2 | X | X | |
LILRA5 | X | X | |
MANEA | X | ||
MEFV | X | X | |
MKI67 | X | X | |
MT2A | X | X | |
MX1 | X | X | X |
MX2 | X | X | |
NADK | X | X | |
NUB1 | X | X | |
OAS1 | X | X | X |
OAS2 | X | X | |
OAS3 | X | X | X |
OASL | X | X | X |
PARP9 | X | X | X |
PHF1 | X | ||
PIK3AP1 | X | ||
PIK3R3 | X | X | |
PLCD3 | X | ||
PLEK | X | X | |
PLEKHO1 | X | ||
PLSCR1 | X | X | X |
PRIM1 | X | X | |
PTMA | X | ||
PTPN18 | X | ||
RELB | X | X | |
RFX5 | X | X | |
RNF213 | X | X | |
RRAGC | X | X | |
RRP1B | X | ||
RSAD2 | X | X | |
SAMD9L | X | X | |
SAMSN1 | X | X | |
SMCHD1 | X | X | |
SP110 | X | X | X |
SPATS2L | X | X | |
SRSF3 | X | ||
STAT1 | X | X | X |
STAT2 | X | X | X |
TF | X | ||
TGFB1 | X | ||
TNFAIP8L2 | X | ||
TNFSF10 | X | X | |
UBE2L6 | X | X | X |
USP18 | X | X | X |
VWA8 | X | ||
WARS | X | X | |
WIPF1 | X | ||
ZBP1 | X | X |
A list of identified upregulated proteins that are known to be involved in IFN-mediated antiviral signaling (type I, II, or III) as annotated in the Interferome database (47).